A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs

[1]  H. Riedel.  Models for Tumour Growth and Differentiation , 2007 .

[2]  E. Lam,et al.  Cell proliferation and cell death , 2006 .

[3]  G. Patton,et al.  Cell-cycle dependence of foamy virus vectors. , 2004, The Journal of general virology.

[4]  J. Pinski,et al.  A new screening system for proliferation-independent anti-cancer agents. , 2004, Cancer letters.

[5]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[6]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[7]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[8]  B. Kaina.  DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. , 2003, Biochemical pharmacology.

[9]  J. Carroll,et al.  p27Kip1 Induces Quiescence and Growth Factor Insensitivity in Tamoxifen-treated Breast Cancer Cells , 2003 .

[10]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[11]  H. Nagawa,et al.  Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. , 2003, Cancer research.

[12]  C. Cordon-Cardo,et al.  p27 as a target for cancer therapeutics. , 2003, Cancer cell.

[13]  S. Okada,et al.  Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma. , 2001, Gynecologic Oncology.

[14]  Chi V. Dang,et al.  Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression* , 2001, The Journal of Biological Chemistry.

[15]  M. Shah,et al.  The relevance of drug sequence in combination chemotherapy. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[16]  J. Jardillier,et al.  Multicellular resistance: a paradigm for clinical resistance? , 2000, Critical reviews in oncology/hematology.

[17]  J. Gerdes,et al.  The Ki-67 protein: fascinating forms and an unknown function. , 2000, Experimental cell research.

[18]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[19]  R. Poon,et al.  Differential responses of proliferating versus quiescent cells to adriamycin. , 1999, Experimental cell research.

[20]  K. Ono,et al.  Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments. , 1999, Radiation medicine.

[21]  D. Gewirtz,et al.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. , 1999, Biochemical pharmacology.

[22]  J. Cheville,et al.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.

[23]  D. Siemann.  The tumor microenvironment: a double-edged sword. , 1998, International journal of radiation oncology, biology, physics.

[24]  G Hamilton,et al.  Multicellular spheroids as an in vitro tumor model. , 1998, Cancer letters.

[25]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[26]  R. Kerbel,et al.  Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.

[27]  S. Lippard,et al.  Cisplatin and DNA repair in cancer chemotherapy. , 1995, Trends in biochemical sciences.

[28]  K. Franssila,et al.  Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer? , 1995, British Journal of Cancer.

[29]  R W Veltri,et al.  Implication of cell kinetic changes during the progression of human prostatic cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[31]  H. Magdelenat,et al.  Prognostic Value of the S‐Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy , 1993, Annals of the New York Academy of Sciences.

[32]  T. H. van der Kwast,et al.  Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. , 1989, The Journal of urology.

[33]  M. Rousset,et al.  Growth-related glycogen levels of human intestine carcinoma cell lines grown in vitro and in vivo in nude mice. , 1980, Journal of the National Cancer Institute.

[34]  L. V. van Putten,et al.  Proliferation-dependent cytotoxicity of anticancer agents: a review. , 1975, Cancer research.

[35]  Inch Wr,et al.  Growth of nodular carcinomas in rodents compared with multi-cell spheroids in tissue culture. , 1970 .

[36]  M. Hall,et al.  Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models. , 2004, Biochemical pharmacology.

[37]  T. Petit,et al.  Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. , 2004, European journal of cancer.

[38]  J. Carroll,et al.  p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. , 2003, Cancer research.

[39]  Shaun Thomas,et al.  Cell Proliferation and Cell Death , 2002 .

[40]  M. Clayton,et al.  Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours. , 1997, British Journal of Cancer.

[41]  R. Jackson,et al.  The problem of the quiescent cancer cell. , 1989, Advances in enzyme regulation.

[42]  R. Sutherland,et al.  Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. , 1971, Journal of the National Cancer Institute.

[43]  R. Sutherland,et al.  Growth of nodular carcinomas in rodents compared with multi-cell spheroids in tissue culture. , 1970, Growth.